Protocol AngCN-CCG-RT22

Radiotherapy for Penis Cancer

Penis
Surgery 85%

Stage 1 very small Electron beam

Curative superficial lesions 64Gy in 32 #
treatment

Interstitial
Selected TI,I<4cms, brachytherapy
invasion of corpora 65Gy to 85%
cavernosa isodose in
6-7 days

All other Stage II,III in patients

stages unfit for or refusing surgery EBRT

Adjuvant nodal RT to ipsilateral groin

Single + node with extra-
treatment 50Gy in 25#
capsular extension

Page 1 of 3 Approved and Published

/conversion/tmp/activity_task_scratch/766617652.doc
 RT to inguinal and pelvic nodes
Multiple/bilateral nodes 50Gy in 25#

Page 2 of 3 Approved and Published

/conversion/tmp/activity_task_scratch/766617652.doc
1 1 MONITORING THE EFFECTIVENESS OF THE PROCESS
a) Process for Monitoring compliance and Effectiveness - Review of compliance as determined by audit. Any non compliance to be presented by QA
Manager to the AngCN Business Meeting on an annual basis – the minutes of this meeting are retained for a minimum of five years.

b) Standards/Key Performance Indicators – This process forms part of a quality system working to, but not accredited to, International Standard BS EN
ISO 9001:2008. The effectiveness of the process will be monitored in accordance with the methods given in the quality manual, AngCN-QM

1.1 Equality and Diversity Statement

This document complies with the Suffolk PCT Equality and Diversity statement – an EIA assessment is available on request to Anglia Cancer Network PQ
Manager, Gibson Centre, Exning Road, Newmarket, CB8 7JG.

1.2 Disclaimer
It is your responsibility to check against the electronic library that this printed out copy is the most recent issue of this document.
Please notify any changes required to the Anglia Cancer Network Quality Assurance Manager

1.3 Document management

Document ratification and history
Approved by: Chair RT Group
Date approved: Date placed on electronic library:
Review period: 2 years (or earlier in the light of new evidence)
Authors: RT Group Document Owner: Anglia Cancer Network, Tel: 01638 608221;
www.angliacancernetwork.nhs.uk
Version number as approved and 1 Unique identifier no.: AngCN-CCG-RT22
published:

Page 3 of 3 Approved and Published

/conversion/tmp/activity_task_scratch/766617652.doc